Conflict Minerals Policy Statement

Follow

today’s conversation on PULSE, the St. Jude Medical blog.

Conflict Minerals Policy Statement

On August 22, 2012, the U.S. Securities and Exchange Commission (SEC) issued the final conflict minerals rule under Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. The rule requires public companies to disclose whether the products they manufacture or contract to manufacture contain “conflict minerals” that are “necessary to the functionality or production” of those products. 

Conflict minerals refer to tin, tantalum, tungsten and gold (commonly referred to as “3TG”), regardless of where they are sourced, processed or sold. The intent of these requirements is to further the goal of ending violent conflict in the Democratic Republic of the Congo and in adjoining countries (Covered Countries), which has been financed, in part, by the extraction and trade of conflict minerals. 

St. Jude Medical supports efforts to encourage supply chain transparency and responsible sourcing and is further supportive of the goal of ending violence and human rights violations in the Covered Countries. We are committed to complying with the conflict minerals reporting and disclosure requirements and we expect our suppliers and supply chain partners to support our efforts and implement conflict minerals compliance programs. We will work with our suppliers in this regard by, among other things, seeking conflict minerals declarations regarding the origin of the conflict minerals in products and parts they supply to us using the Conflict-Free Sourcing Initiative’s Conflict Minerals Reporting Template.